Breaking News
October 20, 2018 - Newly discovered compound shows potential for treating Parkinson’s disease
October 20, 2018 - High rate of non-adherence to hormonal therapy found among premenopausal early breast cancer patients
October 20, 2018 - Immunotherapy medicine found to be effective in treating uveitis
October 20, 2018 - The Pistoia Alliance Calls for Greater Collaboration to Realise Benefits of Innovation and Announces Winners of the 2018 President’s Startup Challenge
October 20, 2018 - Female internists consistently earn less than men
October 20, 2018 - Stanford team looks at dangers of teens’ vaping habits
October 20, 2018 - New approach to understanding cancers will accelerate development of better treatments
October 20, 2018 - LJI and UC San Diego awarded $ 4.5 million as part of NCI’s Cancer Moonshot initiative
October 20, 2018 - School-based HPV vaccination did not increase risky sexual behaviors among adolescent girls
October 20, 2018 - Eye discovery to pave way for more successful corneal transplants
October 20, 2018 - New analysis examines the importance of location in the opioid crisis
October 20, 2018 - Green filters increase reading speed for children with dyslexia
October 19, 2018 - Bariatric Sx Cuts Macrovascular Complications in Obesity, T2DM
October 19, 2018 - Better assessments for early age-related macular degeneration
October 19, 2018 - Visible and valued: Stanford Medicine’s first-ever LGBTQ+ Forum | News Center
October 19, 2018 - Understanding of metal-free enzymes used by bacteria could lead to new effective antibiotics
October 19, 2018 - Beckman Coulter Life Sciences announces new research-focused website
October 19, 2018 - Study finds link between refined soluble fibers, gut microbiota and liver cancer
October 19, 2018 - Social media reduces risk of depression among seniors with pain
October 19, 2018 - Newly developed synthetic DNA molecule may one day be used as ‘vaccine’ for prostate cancer
October 19, 2018 - Preoperative weight loss may not provide health benefits after surgery
October 19, 2018 - U.S. Birth Rates Continue to Drop as Age of New Moms Rises
October 19, 2018 - New technology can keep an eye on babies’ movements in the womb
October 19, 2018 - Juul e-cigarettes pose addiction risk for young users | News Center
October 19, 2018 - Gene sequencing reveals crucial molecular aspects of Trypanosoma brucei
October 19, 2018 - New DNA vaccine strategy protects mice against lethal challenge by multiple H3N2 viruses
October 19, 2018 - Study shows close link between cytokine interleukin-1ß and obesity-promoted colon cancer
October 19, 2018 - Muscle mass plays a critical role in health, shows research
October 19, 2018 - Study finds undiagnosed prediabetes in many infertile men
October 19, 2018 - The Current issue of “The view from here” is concerned with Nanotherapeutic strategies
October 19, 2018 - Delay in replacing the Pap smear with HPV screening is costing lives
October 19, 2018 - Physicians battle pediatric diseases of ear, nose, throat in Zimbabwe | News Center
October 19, 2018 - Researchers investigate why some cancers affect only young women
October 19, 2018 - Drugmakers funnel millions to lawmakers; a few dozen get $100,000-plus
October 19, 2018 - Unselfish people tend to have more children and receive higher salaries
October 19, 2018 - New findings reveal potential cellular players in tumor microenvironment
October 19, 2018 - Human brain cell transplant offers insights into neurological conditions
October 19, 2018 - Parental education associated with increased family health care spending
October 19, 2018 - New statistical method estimates long- and short-term risk of recurrence of breast cancer in US women
October 19, 2018 - Father’s exposure to nicotine may cause cognitive deficits in descendants
October 19, 2018 - Could we prevent Alzheimer’s disease by treating herpes?
October 19, 2018 - Nurse-led care can be more successful in managing gout
October 19, 2018 - Trump administration, pharma exchange verbal volleys on drug-price transparency
October 19, 2018 - Duke researchers find way to detect blood doping in athletes
October 19, 2018 - Many primary care doctors are still prescribing sedative drugs for older adults
October 19, 2018 - Finger length can predict sexuality in women say researchers
October 19, 2018 - Study finds differences in side-effects experienced by male and female OG cancer patients
October 19, 2018 - Dysfunction of single gene leads to miscarriages
October 19, 2018 - Few Seniors Who Self-Harm Referred for Mental Health Care
October 19, 2018 - Don’t sweat the sweet stuff
October 19, 2018 - URMC researchers discover new approach to deliver therapeutics to the brain
October 19, 2018 - Speech Pathology Australia raises awareness about Developmental Language Disorder
October 19, 2018 - Middlemen suppliers can increase drug prices and hospital bills, say Johns Hopkins researchers
October 19, 2018 - Survey finds high prevalence of HTLV-1 infection among teens and adults in Gabon
October 19, 2018 - Bliss funds research to find whether parental touch can help alleviate pain in premature infants
October 19, 2018 - Human neurons employ highly compartmentalized signaling, study shows
October 19, 2018 - Ultromics expands multiple clinical trials for coronary heart disease to the U.S.
October 19, 2018 - $11 million NIH grant for Clemson University helps launch new center for musculoskeletal research
October 19, 2018 - A new approach identified to control Zika virus, dengue fever
October 19, 2018 - Head Blows Without Concussion May Not Damage Brain, Study Claims
October 19, 2018 - US opioid use not declined, despite focus on abuse and awareness of risk
October 19, 2018 - Next-generation RNA sequencing technology sheds new light on human mitochondrial diseases
October 19, 2018 - UT Southwestern biochemist receives 2019 Breakthrough Prize in Life Sciences for innate immunity discovery
October 19, 2018 - The immune system also plays a key role in day-to-day function of healthy organs
October 19, 2018 - New tool may reveal how the brain structure impacts brain activity, human behavior
October 19, 2018 - Trump Administration announces ‘Winning on Reducing Food Waste’ initiative
October 19, 2018 - For-profit nursing home residents more likely to experience health issues caused by substandard care
October 19, 2018 - Incidence of stroke has risen steadily among marijuana users, show studies
October 19, 2018 - Conceptual framework proposed to examine role of exercise in multiple sclerosis
October 19, 2018 - Near infrared spectroscopy technique for accurate evaluation of chondral injuries
October 19, 2018 - Scientists receive $5.1 million grant to develop stem cell-based therapy for blinding retinal conditions
October 19, 2018 - Shorter physician encounters associated with antibiotic prescribing
October 19, 2018 - In the Spotlight: Enjoying research and exploring opportunities
October 19, 2018 - Physical activity lowers cardiovascular mortality risk in frail older adults
October 19, 2018 - New imaging tool helps visualize how sound-induced vibrations travel through the ear
October 19, 2018 - Key insights into the application, production of bioactive materials
October 19, 2018 - New urea sorbent could speed up the development of wearable artificial kidney
October 19, 2018 - Intensive care patients’ muscles less able to use fats for energy
October 19, 2018 - FDA Advisory Committee Recommends Approval of Dsuvia for the Treatment of Moderate-to-Severe Acute Pain
October 19, 2018 - 48,XXXY syndrome – Genetics Home Reference
Columbia Opioid Symposium Calls for Research, Action

Columbia Opioid Symposium Calls for Research, Action

image_pdfDownload PDFimage_print

Speakers at an opioid symposium sponsored by the Irving Institute for Clinical and Translational Research are, from left, Harold Pincus, MD; Mary Bassett, MD, MPH; Carlos Blanco, MD, PhD; Mark Olfson, MD, MPH; and Frances Levin, MD. (Photo credit: Chris Leary Photography)

Speakers at an opioid symposium this summer at Columbia University Irving Medical Center challenged participants to reverse the crisis’s grim statistics. In the U.S., opioid overdose deaths have nearly quadrupled since 1999 to more than 64,000 per year, and they account for 20 percent of deaths in young adults. Yet according to the Department of Health and Human Services, just 20 percent of individuals with an opioid use disorder receive any kind of treatment.

Reducing opioid use and overdoses will take more research, most speakers emphasized. Already at Columbia and NewYork-Presbyterian Hospital, such work is getting underway. An opioid brainstorm session was convened late last year to foster collaboration among researchers at Columbia, NewYork-Presbyterian Hospital, industry partners, and the community—and led to the formation of working groups focused on prescribing and pain management, addiction treatment, community engagement, and bench-to-bedside research on pain and addiction. (The session was organized by Columbia’s NIH Clinical and Translational Science Award Program and overseen by the Irving Institute for Clinical and Translational Research, a partnership between Columbia and NewYork-Presbyterian.) The meeting coincided with other initiatives—including NewYork-Presbyterian Hospital’s efforts to monitor and alter opioid prescribing and to increase community-based treatment of addiction.

“With these groups, we’re hoping to spark new ideas and new collaborations about how to address the opioid epidemic,” said Muredach Reilly, MBBCh, MSCE, director of the Irving Institute, Herbert and Florence Irving Professor of Medicine at Columbia University Vagelos College of Physicians and Surgeons (VP&S), and an attending physician at NewYork-Presbyterian Hospital.

“We need research and solutions to address the many narratives underlying this crisis—overmedication of chronic pain, undertreatment of opioid use disorder, and systemic medical system, societal, and legal failures—in order to stop people from dying.”

The symposium coincided with the recent launch of the NIH’s HEAL initiative, a $500 million research program to fund interdisciplinary research on addiction and pain.

The participants discussed current approaches toward preventing opioid use disorder and overdose—and how to improve those approaches. Carlos Blanco, MD, PhD, director of epidemiology, services, and prevention research at the National Institute on Drug Abuse, said prevention needs to be a priority, not an afterthought. To do that, he said, more research about who is at risk is needed.

Patients who appear to be most at risk of death from opioid overdose and related problems are those being treated for chronic pain, according to research from Mark Olfson, MD, MPH, professor of psychiatry at VP&S. “Many of these deaths occurred in people who had been prescribed opioids in combination with benzodiazepines in the final month of life, showing us that we have a fair amount of work to do to improve the safety of pain management,” he said.

“We have a fair amount of work to do to improve the safety of pain management,” said Mark Olfson, MD, MPH. (Photo credit: Chris Leary Photography)

The crisis also has affected its victims in other ways that we are just beginning to understand. “A great deal of attention has been placed on the risk of overdose deaths following nonfatal overdoses, but our latest study showed that individuals who survive a nonfatal overdose are also at increased risk of dying from a number of medical conditions, including circulatory and respiratory diseases, suicide, and HIV,” said Olfson.

We need to be more aggressive about using MAT, which will involve overcoming numerous barriers.

For individuals with opioid use disorder, proven treatments are available but underused. Medication addiction therapy (MAT)—including naltrexone, buprenorphine, and methadone—reduces the risk of relapse, overdose, and mortality, said Frances Levin, MD, the Kennedy-Leavy Professor of Psychiatry at VP&S and chief of the Division on Substance Use Disorders at Columbia University Irving Medical Center/New York State Psychiatric Institute. But out of the 20 percent of individuals with opioid use disorder who get treatment, less than a third are treated with MAT. “We need to be more aggressive about using MAT, which will involve overcoming numerous barriers to using and prescribing these medications,” said Levin, who also is a psychiatrist at NewYork-Presbyterian.

MAT medications are often hard to access outside of major metropolitan areas, explaining one barrier. Patients also must remain abstinent for a week before one of the medications (naltrexone) can be used. To remedy these problems, Levin said that faculty at Columbia are working to expand implementation of MAT in community-based settings and to improve naltrexone induction. Other treatments, including opioid vaccines, game-based interventions, and phrenic nerve stimulation to reverse overdose, are also being developed.

Rural America garners much of the media attention on the opioid epidemic, but cities are also affected. Since the introduction of fentanyl to the New York City market a few years ago, someone in our city dies of an opioid overdose every seven hours, said Mary Bassett, MD, MPH, commissioner of the New York City Department of Health and Mental Hygiene.

Slide from NYC Department of Health and Mental Hygiene

New York City has been tackling the opioid crisis on a variety of fronts. Mayor DeBlasio committed $60 million to train 1,500 providers in MAT prescription, open syringe exchange sites in areas most affected by overdose deaths, and develop media campaigns to destigmatize addiction treatment. The investment also will expand the city’s Relay overdose response system, which positions wellness advocates in hospital emergency rooms to guide overdose survivors toward treatment. Bassett also reported that, following a directive from the mayor’s office, 960 pharmacies now offer naloxone, which reverses opioid overdose, without a prescription.

The symposium ended with two concurrent sessions and panel discussions. One session, led by Beatrice Ellerin, director of the Healthcare and Pharmaceutical Management Program at the Columbia Business School, focused on the industry response to the crisis; another, led by the Community Engagement Core Resource of the Irving Institute with NewYork-Presbyterian Hospital, Columbia School of Social Work, and the Washington Heights Corner Project, focused on community responses to the crisis.

In the months ahead, the Irving Institute and partners will continue to challenge and engage researchers, government, and industry and community leaders in tackling the opioid crisis through research and action. “By sparking new ideas and new collaborations, providing seed funding for initial steps, and empowering our working groups to respond to the NIH Heal Initiative and other funding opportunities, we will continue to work with our partners to facilitate research and implementation of science-based solutions to address the many facets of this national crisis,” concluded Reilly.

Tagged with:

About author

Related Articles